Search - tctmd.com

Displaying 961 - 980 of 1588

Sort: Relevancy | Date

News Daily News

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Michael O'Riordan

December 20, 2015

News Daily News

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Caitlin E. Cox

December 20, 2015

Presentation

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

Presenter: PA. Gurbel

December 16, 2015

News Daily News

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Michael O'Riordan

December 15, 2015

News Daily News

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Michael O'Riordan

December 15, 2015

News Daily News

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Michael O'Riordan

December 15, 2015

News Daily News

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

Caitlin E. Cox

December 15, 2015

News Daily News

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

Todd Neale

December 14, 2015

News Daily News

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

L.A. McKeown

December 14, 2015

News Daily News

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

L.A. McKeown

December 14, 2015

News Daily News

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

L.A. McKeown

December 14, 2015

News Daily News

Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI

Todd Neale

December 14, 2015

News Daily News

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Yael L. Maxwell

December 14, 2015

News Daily News

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Todd Neale

December 14, 2015

Presentation

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

Presenter: Vivek Y. Reddy

December 13, 2015

News Daily News

与他汀类药物相关的负面新闻与停药和心血管风险增加有关

Michael O'Riordan

December 02, 2015

News Daily News

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Michael O'Riordan

December 02, 2015

News Daily News

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Michael O'Riordan

December 02, 2015

Presentation

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Presenter: Sune Nielsen

December 01, 2015

News Daily News

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

November 29, 2015

Advertisement

Performance Metrics Revised for Statins Post-MI, After PCI, and in CAD Patients

Early Data Show Promise for Reversible, Fast-Acting, Antiplatelet Drug PZ-128

Cell-Penetrating Pepducin Therapy Targeting PAR-1 in Subjects With CAD

依泽替米贝减少心血管事件的说法未能获得 FDA 顾问委员会的支持

Un Comité Asesor de la FDA No Avala la Afirmación de que Ezetimibe Reduce los Episodios CV

Ezetimibe Fails to Garner Support for CV- Event Reduction Claim From FDA Advisory Committee

Un Subestudio del CvLPRIT Halla Pequeños Daños Pasajeros en PCI de Arterias No Infartada

研究表明 PCI 进展会削弱比伐卢定在出血风险方面的优势

研究肯定了 Watchman 左心耳封堵器减少卒中的成本效益

Un Estudio Confirma la Rentabilidad del Dispositivo Watchman para el Cierre del AAI en el Descenso de ACV

Study Affirms Cost-Effectiveness of Watchman LAA Closure Device for Stroke Reduction

Según un Análisis los Beneficios Hemorrágico de la Bivalirudina Disminuyen a medida que Avanza la PCI

Case Study Highlights Risks for A-fib Patients Undergoing PCI in Absence of Evidence-Based Guidelines

Bivalirudin’s Bleeding Benefits Dampened by PCI Advances, Analysis Shows

Time to Cost-Effectiveness After Stroke Reduction Strategies in A-fib: Warfarin vs Novel Oral Anticoagulants (NOACs) vs Left Atrial Appendage (LAA) Closure

与他汀类药物相关的负面新闻与停药和心血管风险增加有关

Negative Statin-Related News Linked With Drug Discontinuation, Increased CV Risk

Las Noticias Negativas sobre las Estatinas se asociaron a su Interrupción y a Más Riesgo CV

Negative Statin-Related News Stories Decrease Statin Persistence and Increase MI-CV Mortality

Un Meta Análisis Avala el Mayor Uso del Abordaje Radial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content